NeuPath Health Third Quarter 2024 Earnings CA0.007 loss per share - Yahoo Finance
| NPTH Stock | CAD 0.17 0.01 6.25% |
Slightly above 55% of NeuPath Health's sophisticated investors are presently thinking to get in. The analysis of overall sentiment of trading NeuPath Health stock suggests that some investors are interested at this time. NeuPath Health's investing sentiment can be driven by a variety of factors including economic data, NeuPath Health's earnings reports, geopolitical events, and overall market trends.
NeuPath Health stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of NeuPath daily returns and investor perception about the current price of NeuPath Health as well as its diversification or hedging effects on your existing portfolios.
NeuPath |
NeuPath Health Third Quarter 2024 Earnings CA0.007 loss per share Yahoo Finance
Read at news.google.com
 |
NeuPath Health Fundamental Analysis
We analyze NeuPath Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of NeuPath Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of NeuPath Health based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Profit Margin
Profit Margin Comparative Analysis
NeuPath Health is currently under evaluation in profit margin category among its peers. Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
NeuPath Health Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with NeuPath Health stock to make a market-neutral strategy. Peer analysis of NeuPath Health could also be used in its relative valuation, which is a method of valuing NeuPath Health by comparing valuation metrics with similar companies.
Peers
NeuPath Health Related Equities
| DHT-U | DRI Healthcare | 5.17 | ||||
| ROMJ | Rubicon Organics | 3.13 | ||||
| FOOD | Goodfood Market | 2.27 | ||||
| HLF | High Liner | 0.98 | ||||
| RHT | Reliq Health | 0.00 | ||||
| NWH-UN | NorthWest Healthcare | 0.40 |
Additional Tools for NeuPath Stock Analysis
When running NeuPath Health's price analysis, check to measure NeuPath Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NeuPath Health is operating at the current time. Most of NeuPath Health's value examination focuses on studying past and present price action to predict the probability of NeuPath Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NeuPath Health's price. Additionally, you may evaluate how the addition of NeuPath Health to your portfolios can decrease your overall portfolio volatility.